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Abstract
Prominin1 (Prom1, also known as CD133 in human) has been widely used as a marker for cancer stem cells (CSCs), which
self-renew and are tumorigenic, in malignant tumors including glioblastoma multiforme (GBM). However, there is other
evidence showing that Prom1-negative cancer cells also form tumors in vivo. Thus it remains controversial whether Prom1 is
a bona fide marker for CSCs. To verify if Prom1-expressing cells are essential for tumorigenesis, we established a mouse line,
whose Prom1-expressing cells can be eliminated conditionally by a Cre-inducible DTA gene on the Prom1 locus together
with a tamoxifen-inducible CreER
TM, and generated glioma-initiating cells (GICs-LD) by overexpressing both the SV40 Large
T antigen and an oncogenic H-Ras
L61 in neural stem cells of the mouse line. We show here that the tamoxifen-treated GICs-
LD (GICs-DTA) form tumor-spheres in culture and transplantable GBM in vivo. Thus, our studies demonstrate that Prom1-
expressing cells are dispensable for gliomagenesis in this mouse model.
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Introduction
Recent findings have demonstrated that malignant tumors,
including glioblastoma multiforme (GBM), contain cancer stem
cells (CSCs), which self-renew and are tumorigenic [1]. Prom1 has
been utilized extensively to identify and enrich CSCs from many
tumors, including lung cancers, colon cancers, hepatocellular
carcinomas, and brain tumors [2–6], using the specific anti-Prom1
antibody that recognizes the glycosylated-form of Prom1 [7].
CSCs as well as tissue-specific stem cells (TSCs) in hypoxic niches
are likely dormant, and resistant to anti-cancer drugs and
irradiation [8,9]. Moreover, it was shown that TSCs are fostered
in these niches [10,11] and can transform into CSCs when they
acquire oncogenic mutations [12]. These, together with the
finding that hypoxia induces Prom1 expression [13], suggest that
both TSCs and CSCs would be positive for Prom1 in the niche.
However, it remains controversial whether Prom1 is a bona fide
marker for CSCs as it has been indicated that Prom1-negative
glioma cell lines in normoxia become positive for Prom1 in
hypoxia, which is one of the characteristics of GBM, and that its
expression is reversible upon re-oxygenation [13]. Moreover, there
is increasing evidence that Prom1-negative cancer cells from
GBMs [14], colon cancers [15], and the Daoy medulloblastoma
cell line [16] can form tumors when transplanted in vivo. Thus,
these findings raise the possibility that CSCs can alter their Prom1
expression, depending on the culture condition and microenvi-
ronment in vivo.
In order to confirm whether Prom1-expressing cells are essential
for tumorigenesis, we established mouse glioma-initiating cell
(GIC) lines by overexpressing both SV40 Large T antigen
(SV40LT) and a constitutive-active form of H-Ras (HRas
L61)i n
neural stem cells (NSCs), whose Prom1-expressing cells can be
eliminated genetically. We show here that Prom1 expression is
induced in the peripheral cells of tumor-spheres in culture and a
portion of glioma in vivo as shown in human GBM [5–6,14]. We
demonstrate that the induced GIC population depleted of Prom1-
expressing cells form tumor-spheres in culture and transplantable
GBM in vivo. Thus, these results suggest that Prom1-expressing
glioma cells are not essential for tumorigenesis in this mouse
model.
Results and Discussion
Generation of Prom1 knock-in mice
We replaced the second exon, which contains the first ATG
codon on the Prom1 locus, with a floxed-lacZ and DTA
(Prom1
lacZ,DTA/+) [17,18] (Figure 1A and 1B) and generated
Prom1
lacZ,DTA/+ mice that develop normally and are fertile. We
also obtained adult Prom1
lacZ,DTA/lacZ,DTA mice as reported by
another Prom1 knock-in allele [12] and found that they are also
viable and develop normally, indicating that Prom1 is not essential
for development and our transgene is not toxic.
Prom1 expression in embryonic and adult central
nervous system
Whole-mount X-gal staining revealed widespread b-galactosi-
dase (b-gal) activity in the developing central nervous system
where NSCs exist in abundance (Figure 1C). We detected b-gal
activity in the ventricular zone (VZ) of E9.5 embryos to neonatal
mice, confirming that Prom1 is expressed in NSCs in the
developing brains (Figure S1). Although immunoreactivity of
PLoS ONE | www.plosone.org 1 August 2009 | Volume 4 | Issue 8 | e6869Prom1 antibody was detected only in the VZ in the adult brain
(Figure S2) [19], we found b-gal activity in the cerebellum,
midbrain, olfactory bulb, hippocampus, and telencephalon as well
(Figure 1D and S2). One possible explanation for the difference
observed between our findings and previous findings is that the
commercially available anti-Prom1 antibodies recognize limited
numbers of Prom1 splicing variants, such as Prom1-s1 [20],
whereas the expression of all of the splice variants may be
sensitively detected in our knock-in mice.
Detailed analyses revealed that Prom1 is expressed in the
granular layer of the cerebellum, where the interneurons exist, and
in the glomeruli of the olfactory bulb, which are composed of
axons of olfactory cells and dendrites of olfactory bulb interneu-
rons. (Figure 1D). We also found that 69% of b-gal-positive cells
are labeled for S100b in the hippocampus where NSCs exist in the
dentate gyrus (Figure 1D and 2A–2C). In VZ of lateral ventricle,
90% and 9.5% of b-gal-positive cells are labeled for S100b
(ependymal cells, Figure 2D–2F) and GFAP (SVZ astrocytes,
Figure 2Q), respectively. We also found that 7.9% of GFAP-
positive SVZ astrocytes are positive for Prom1 (Figure 2Q and
2R), consistent with the past finding that Prom1 is expressed in
multipotent SVZ astrocytes in the adult brain [21]. In the corpus
callosum, the b-gal activity was detected in S100b-positive
astrocytes and GSTp-positive oligodendrocytes, but not in
NeuN-positive neurons, NG2-positive oligodendrocyte precursor
cells, or GFAP-positive astrocytes (Figure 2G–2P). We found
similar tendencies in other white matter, neocortex and midbrain
as shown in Figure 2P. Thus, these data revealed that Prom1 is
expressed in various types of differentiated neural cells as well as
NSCs in the adult brain.
Genetic ablation of Prom1-expressing cells by inducible
Cre recombinase in vivo
To eliminate Prom1-expressing cells conditionally, the
Prom1
lacZ,DTA/+ mice were then crossed with the CAGG-CreER
TM
transgenic mice that ubiquitously express a tamoxifen-inducible
Cre recombinase [22] and generated Prom1
lacZ,DTA/+;CreER
TM
double heterozygotes. Upon the activation of Cre recombinase,
the floxed-lacZ cassette is cut off, leading to the specific
elimination of the Prom1-expressing cells by DTA induced upon
the activation of Prom1 promoter (Figure 3A). We first examined
whether this experimental system works in vivo.A se x p e c t e d ,
after five consecutive days of intraperitoneal injections of
tamoxifen, we induced a number of TUNEL-positive cells in
the granular layer of cerebellum, cortex of telencephalon, white
matter, and midbrain (Figure 3B, 3C and not shown). In
addition, tamoxifen-injected mice lost body weight and showed
a walking abnormality caused by functional defects of the
c e r e b e l l u m .T h e yd i d ,h o w e v e r ,s u r v i v ea tl e a s t1 5d a y sa f t e rt h e
final injection (Figure S3A). It will be of interest to further
investigate how the elimination of Prom1-expressing cells causes
body weight loss in mice. Nonetheless, we could not eliminate
Prom1-expressing cells in VZ of the mice and detected migrating
neuroblasts in the rostral migratory stream (Figure S3B, arrow)
and olfactory bulb, suggesting that neurogenesis was taking
place in the mice (Figure S3B). These data indicate that our
Figure 1. Generation of Prom1 knock-in mice and reporter analysis in the central nervous system. (A) Schematic representation of
targeted allele. (B) Southern blot analysis of three independent heterozygous lines. (C) Whole mount X-gal staining of E12.5 Prom1
lacZ,DTA/+ and WT
embryos. Scale, 2 mm. (D) X-gal staining of frozen sections of adult mouse brains. Upper panel shows the whole brain and lower five panels display
high magnification images of the squared regions in the upper panel. GM, glomeruli; CC, corpus callosum; LV, lateral ventricle; FH, fimbra of
hippocampus; GL, granular layer. Scale, 2 mm (upper panel) and 500 mm (lower panels).
doi:10.1371/journal.pone.0006869.g001
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of DTA induction is dependent on the region or cell types.
Establishment of a mouse model for GBM
To verify whether Prom1-expressing cells are essential for
tumorigenesis, we adopted a GIC transplantation method into nude
mice rather than tumor induction in the Prom1
lacZ,DTA/+;CreER
TM
mice because the DTA induction efficiency is low in the brain as
mentioned above (Figure S3B). To generate a mouse GIC line, we
first transfected NSCs from Prom1
lacZ,DTA/+;CreER
TM line with
pBabe-Puro-SV40LT vector, which blocks both p53 and Rb
pathways, as high frequencies of mutations in p53 (87%) and Rb
(78%) pathways are seen in human GBM [23,24]. Then the
SV40LT-expressing NSCs were transfected with pCMS-EGFP-H-
Ras
L61 vector, as an increased activation of the Ras signaling
pathway is detected in about 90% of human GBM [25], to establish
GIC-Prom1
lacZ,DTA/+;CreER
TM line (GIC-LD). GICs-LD proliferated
faster than their parental NSCs as confirmed by the BrdU
incorporation assay (Figure 4A). We also found that when both
types of cells were cultured under differentiation conditions, GICs-
LD did not show any signs of undergoing differentiation, while their
parental cells were labeled for the neuronal marker Tuj1, glial
markers O4 and glial fibrillary acidic protein (GFAP), and NSC
markers Nestin and Sox2 (not shown) (Figure 4B). Moreover, GICs-
LD formed colonies in soft agar whereas their parental cells did not
(Figure 4C). Together, these data suggest that GICs-LD are
transformed and do not readily differentiate in vitro.
We then addressed whether GICs-LD form tumors in vivo.W e
injected 10
4 cells into brains of nude mice and found that they
formed tumors with histological features similar to human GBM,
including hypercellularity, pleomorphism, multinuclear giant cells,
mitosis, and necrosis [26] (Figure 4D). In addition, we noticed that
the tumors were comprised of Nestin-positive cell populations,
rather than a mixture of NSC marker- and differentiation marker-
positive cells, GFAP+ astrocytes, myelin basic protein (MBP)+
mature oligodendrocytes, and NeuN+ mature neurons, indicating
that the tumor cells maintain characteristics of NSCs and are
unlikely to differentiate in vivo (Figure 4D). We also confirmed
these results by immunolabeling the tumors for GFP and neural
markers (Figure S4).
Figure 2. Prom1 is expressed in mature glial cells and SVZ astrocytes in the adult mouse brain. (A–O) Brain sections of adult Prom1
lacZ,DT-A/+
were double-labeled for b-gal, which represents Prom1 expression, and differentiation markers. In hippocampus and ventricular zone, most b-gal
positive cells stained for S100b (astrocyte and ependymal cell marker; A–F). In corpus callosum, some b-gal-positive cells labeled for S100b (G–I) and
GSTp (mature oligodendrocytes;J–L)but not for GFAP (another marker for astrocytes; M), NeuN (mature neurons; N),or NG2 (oligodendrocyte precursor
cells; O). Scale bars, 10 mm. (P) Quantitative data of differentiation marker-positive cells in b-gal-expressing cells in corpus callosum. Similar trends were
observed in the midbrain, neocortex, and other white matter. (Q) Quantitative data of Prom1- and GFAP-positive cells in b-gal-expressing cells in lateral
ventricle. (R) In ventricular zone, b-gal-expressing cells (red) were partially labeled for Prom1 (green) and GFAP (white). All nuclei were counterstained
with DAPI (blue). Scale bars, 10 mm.
doi:10.1371/journal.pone.0006869.g002
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activation. Tamoxifen-dependent Cre activation deleted the lacZ gene cassette, leading to the induction of DTA expression upon activation of the
Prom1 promoter. (B) Intraperitoneal injection of tamoxifen-induced cell death (red) in cerebellum (left panels) and neocortex in telencephalon (right
panels) as well as midbrain and white matter (not shown). Arrow heads indicate TUNEL-positive cells in the neocortex. All nuclei were counterstained
with DAPI (blue). Scales, 100 mm. (C) The number of TUNEL-positive cells per section were counted in the whole neocortex and in half of one lobule of
the cerebellum. The results shown are the mean6s.e.m. of two independent experiments. *P,0.05. Similar results were also observed in the midbrain
and white matter (not shown).
doi:10.1371/journal.pone.0006869.g003
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especially in the peripheral region of the tumors (Figure 5),
consistent with the previous findings that human GBM contain a
small population of Prom1-positive cells [5–6,14]. To determine
whether Prom1-expressing cells reside in the hypoxic region, we
immunolabeled different sections with either CD31 for blood
vessels or HIF1a for hypoxia in combination with X-GAL
staining. Although Prom1-expressing cells were not labeled for
HIF1a, they were adjacent to the HIF1a-positive hypoxic regions
(Figure S5). In contrast, Prom1-expressing cells were not detected
around or near blood vessels (Figure S5). Thus, these data suggest
that Prom1 expression may be regulated by a HIF1a-independent
hypoxic signal pathway.
The GIC population lacking Prom1-expressing cells can
form tumor-spheres in vitro
We also found that very few GICs-LD were LacZ-positive when
cultured as monolayers, whereas a significant number of these cells
expressed LacZ when they formed spheres, suggesting that the
Prom1 promoter is activated by cell adhesion and cell-to-cell
communication (Figure 6A). To test whether the Prom1-expressing
cancer cells are essential for tumorigenesis in this system, we
generated GICs-Prom1
DTA/+;CreER
TM (GICs-DTA) by culturing
GICs-LD as a monolayer with 4-hydroxy-tamoxifen, and then
established two independent GICs-DTA sublines using limiting
dilution methods. The genotype of the sublines was confirmed
Figure 4. Characteristics of the GICs-LD. (A) Proliferation of the GICs-
LD and their parental cells (NSCs) was determined by BrdU incorporation
assay. The results shown are the mean6SD of three cultures. *P,0.05. (B)
The proportion of neural lineage marker-positive cells is shown as the
mean6SDof twocultures. *P,0.05;**P,0.01. (C) Colony formation ability
was examined in soft agar. (D) Brain sections with tumors derived from
GICs-LD were stained with hematoxylin and eosin (HE) and for Nestin,
GFAP, MBP, and NeuN. Scales, 2 mm (upper left panel), 100 mm (upper
right panel), and 200 mm (middle and lower panels).
doi:10.1371/journal.pone.0006869.g004
Figure 5. Prom1 is expressed in the periphery of brain tumors.
Serial brain sections with tumors were stained with HE (upper panels)
and X-gal (lower panels). Section #1a n d#2w e r ef r o mt w o
independent regions of the brain. Right panels indicate the high
magnification images of the squared region of left panels. X-gal-positive
cells were detected in the peripheral region of tumors. Scales, 2 mm
(left panels) and 200 mm (right panels).
doi:10.1371/journal.pone.0006869.g005
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[27], we confirmed that when the Prom1 promoter was activated
by a histone deacetylase inhibitor, valproic acid (VPA, 10 mM),
over 90% of the cells in GICs-DTA sublines died within 2 days,
while over 60% of their parental GICs-LD lines survived under
the same conditions (Figure 6A–6C). It was believed that Prom1-
positive cells are required for the formation of tumor-spheres in
vitro [8–9,14], however, we found that GICs-DTA sublines can
proliferate and form spheres with no observable defects
(Figure 6D), indicating that Prom1-expressing cells are not essential
for the maintenance of GIC population in culture.
GBM formation from the cell population depleted of
Prom1-expressing cells
GICs-DTA sublines were then transplanted into the brains of
nude mice. Both sublines produced brain tumors with similar
characteristics to their control tumors (Figure 4D and 7A) and
human GBM [26], and led to the death all of the mice like their
parental GICs-LD (n=4 for each cell lines, P=0.65) (Figure 7B).
We could not detect LacZ-positive cells in the tumors, confirming
that tumors derived from GICs-DTA sublines do not have any
Prom1-expressing cells (not shown). Furthermore, we performed
serial transplantation experiments, and found that all of the mice
(n=3) that received secondary transplantation developed brain
tumors that were phenocopies of primary ones (data not shown)
and died within 30 days (Figure 7C), indicating that GIC-DTA
sublines have high capacity for self-renewal. Taken together, these
data reveal that Prom1-expressing cancer cells are not essential for
tumorigenesis and its maintenance in this GBM model.
Using the Prom1 knock-in allele, we demonstrated that Prom1 is
predominantly expressed in differentiated cells as well as NSCs in
the adult brain and that mouse GIC populations that eliminate
Prom1-expressing cells can proliferate in culture and form
transplantable GBM in vivo, suggesting that Prom1 is not a specific
marker for NSCs or GICs. However, we cannot exclude the
possibility that Prom1-positive glial cells may behave as multipotent
NSCs as shown previously [19,28] and that Prom1-positive GICs
may be more malignant than other GICs and are essential for
tumorigenesis in other glioma models. It also remains to be
evaluated whether human GIC population depleting Prom1-
expressing cells can form malignant glioma in vivo. Using the
Prom1
lacZ,DTA/+ mice, it is important to clarify whether Prom1-
expressing cells are essential for the tumorigenesis of other cancers,
including breast, intestinal, and prostate cancers. Thus our
Prom1
lacZ,DTA/+ micewill be a usefultool forthe researchcommunity
to examine the functions of Prom1-expressing cells, which exist
Figure 6. Prom1-expressing cells are dispensable for maintaining GICs in culture. (A) X-gal staining of monolayer-cultured GICs-LD
(Monolayer), their tumor spheres (Sphere), and valproic acid (VPA, 10 mM)-treated cells (lower panels; representative data from three cultures).
(B) VPA induced TUNEL-positive cell death in GICs-DTA. All nuclei were counterstained with DAPI (blue). Scales, 100 mm (C) Survival of GICs-LD and
GICs-DTA was determined by MTT assay. The results shown are the mean6s.e.m of three cultures. *P,0.001. (D) Sphere formation of GICs-LD and
GICs-DTA. Upper schemes indicate the structures of the genome. Scale, 60 mm.
doi:10.1371/journal.pone.0006869.g006
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mice that express inducible and tissue-specific Cre recombinase.
Materials and Methods
Mice and Chemicals
Prom1 knock-in mice (Acc. No. CDB0623K: http://www.cdb.
riken.jp/arg/mutant%20mice20list.html) were generated using a
knock-in method as described [29]. To prevent leaky expression of
DTA, a double polyA signal was inserted under the lacZ gene
(http://www.cdb.riken.jp/arg/cassette.html). Prom1 knock-in mice
that were backcrossed and maintained on a C57BL/6 genetic
background, were crossed with ACTB-FLPe mice [30] to delete the
neomycin selection cassette to generate Prom1
lacZ,DTA/+ mice.
Prom1
lacZ,DTA/+ mice were further crossed with CAGG-CreER
TM
mice to delete the lacZ cassette upon Cre activation, generating
Prom1
lacZ,DTA/+;CreER
TM mice. Genotypes of each mouse were
confirmed by Southern blot analysis and PCR. To induce CreER
activation, tamoxifen (Sigma), which was dissolved in sun-flower
oil (20 mg/ml), was injected intraperitoneally into mice (9 mg/
40 g body weight) for 5 consecutive days. The mice were dissected
and analyzed 10 days after the final injection. All mouse
experiments were performed following the protocols approved
by the RIKEN CDB Animal Care and Use Committee.
Chemicals and growth factors were purchased from Sigma and
PeproTech, respectively, except where indicated.
Intracranial cell transplantation into the brain of nude
mice
Control cells and transformed cells were suspended in 5 mlo f
culture medium and injected into brains of 5,8 week-old female
nude mice that had been anesthetized with 10% pentobarbital.
The stereotactic coordinates of the injection site were 2 mm
forward from lambda, 2 mm lateral from the sagittal suture, and
5 mm deep.
For serial transplantation, brain tumors were dissociated
enzymatically using the papain dissociation system (Worthington).
GFP-positive transformed cells were purified using a JSAN flow
cytometer (BayBioscience, Japan), suspended in culture medium,
and transplanted into nude mice soon after sorting.
Cell culture
NSCs were prepared from embryonic day 17.5 Prom1
lacZ,DTA/+;
CreER
TM mouse telencephalon and cultured in DMEM/F12
(Gibco, BRL) supplemented with chemicals, bFGF (10 ng/ml),
and EGF (10 ng/ml) (NSC medium), as described previously [31].
For the monolayer culture, cells were cultured on poly-D-lysine-
(PDL, 15 mg/ml) and fibronectin- (1 mg/ml, Invitrogen) coated
dishes in NSC medium or on non-coated dishes in NSCs medium
with 5% FCS.
To induce neural differentiation, NSCs were cultured on 8-well
chamber slides (Nunc) in DMEM with 1% FCS for one week.
Prom1 expression was induced in the cells cultured with 10 mM
Valproic acid (VPA) (Calbiochem) for 3 days. BrdU incorporation
assay was performed as described previously [32]. To isolate
GICs-DTA sublines, GICs-LD were cultured with 4-hydroxy-
tamoxifen (100 nM) for 4 days. The single cells were then isolated
and cultured in the 96-well dishes to avoid contamination of non-
recombinant cells. Deletion of the lacZ gene in GICs-DTA sublines
was confirmed by PCR analysis (see below).
Southern blot analysis and genotyping
To determine the genome structure of Prom1 knock-in mice,
genomic DNA was digested with XmnIo rBamHI. Digoxigenin
Figure 7. Prom1-expressing cells are not required for the tumorigenesis of GICs in nude mice. (A) Brain sections with tumors derived from
GICs-DTA. The GICs invaded into the brain parenchyma. HE staining of the tumors shows necrosis, hypercellularity and hypervascularity, multinuclear
giant cells, and mitotic cells; these pathological features are similar to human GBM (upper panels). Immunohistochemical analysis of the tumor for
Nestin, GFAP, MBP, and NeuN (middle and lower panels). Scales, 2 mm (upper left panel), 100 mm (upper right panel), and 200 mm (middle and lower
panels). (B) Survival curves for mice (n=4 of each line) injected with 10
4 GICs-LD (green line) and GICs-DTA (red line). No significance was observed,
P=0.65. (C) Survival curve for mice (n=3) serially transplanted with 10
4 GFP-positive primary tumor cells.
doi:10.1371/journal.pone.0006869.g007
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PCR DIG Probe Synthesis kit (Roche). Detailed probe sequences
will be disclosed on request. Hybridization was conducted using
standard protocols. In addition to the external probes (probe A),
internal probes (probe B) were used to detect random integrations
of the targeting vector on the genome.
Genotyping of the knock-in mice was done by PCR. Genomic
DNA was isolated from the mouse tail by standard methods and
then used for PCR. The following oligonucleotide DNA primers
were synthesized: For Prom1 knock-in allele, prom1-fwd: 59-GCT
TGAGAGATCAGG CCAACAAC-39, prom1-rvs: 59-CTAGA-
GGGAAGTCATTCGGCTG-39 and lacZas: 59-CGCGTAA-
AAATGCGCTCAGG-39. The primers for CAGG-CreER
TM and
ACTB-FLPe were as described previously [22,30]. Dimethylsulf-
oxide (DMSO, 5%) was added to the all reaction mixture. Cycle
parameters were 20 sec at 94uC, 30 sec at 60uC, and 40 sec at
72uC for 35 cycles.
RT-PCR was carried out as described previously [32]. For
gapdh, cycle parameters were 10 sec at 94uC, 20 sec at 58uC, and
40 sec at 72uC for 25 cycles. DNA primers for Prom1 were
synthesized: the 59 primer was 59-AGGCTACTTTGAACAT-
TATCTGCA-39 and the 39 primer was 59-GGCTTGTCATAA-
CAGGATTGT-39. Cycle parameters were 10 sec at 94uC, 20 sec
at 58uC, and 40 sec at 72uC for 40 cycles.
Immunochemistry
Immunostaining was carried out as described previously
[32,33]. The following antibodies were used to detect antigens:
rat anti-Prom1 (1:100; eBioscience), mouse anti-BrdU (1:1000;
Hybridoma Bank), rabbit anti-GFAP (1:500; DakoCytomation),
mouse anti-Nestin (1:500; BD Pharmingen), mouse anti-beta
tubulin isotype III (Tuj1; 1:200; Sigma), mouse anti-O4 (1:5;
hybridoma supernatant; ATCC), mouse anti-MBP (1:1000;
COVANCE), mouse anti-NeuN (1:200; Chemicon), rabbit anti-
GFP (1:500; Abcam), rat anti-GFP (1:500; Nacalai Tesque, Japan),
chicken anti-b-gal (1:500; Abcam), rabbit anti-NG2 (1:200;
Chemicon), rabbit anti-S100b (1:500; DakoCytomation), mouse
anti-GSTp (1:100; BD Pharmingen), mouse anti-PSA-NCAM
(1:500; gift from T. Seki, Juntendo University School of Medicine),
mouse anti-HIF1a (1:500; Abcam) and rabbit anti-CD31 (1:50;
Abcam). The antibodies were detected with goat anti-rabbit IgG-
A488, goat anti-mouse IgG-A488 (1:400; Invitrogen), goat anti-
mouse IgG-Cy3, donkey anti-rabbit IgG-Cy3, donkey anti-mouse
IgG-Cy3, donkey anti-chicken IgY-Cy3, donkey anti-rabbit IgG-
Cy5 (1:200; Jackson ImmunoResearch), and rabbit anti-mouse
IgM-Texas-Red (1:200; Jackson ImmunoResearch). To visualize
the nuclei, the cells were counterstained with DAPI (1 mg/ml).
Soft agar assay
We performed a soft agar assay to examine whether the
cultured cells could proliferate anchorage-independently. The cells
were suspended in 0.3% top agar containing optimum medium
and layered onto 0.6% bottom agar made with the same medium.
After the top agar solidified, culture medium was added and the
cells were cultured for 20 days with medium changes every 3 days.
MTT assay
One thousand cells were cultured in 100 ml of culture medium
in each well of the 96-well plates with or without VPA (5
or10 mM) for 2 days. The cells were cultured in the presence of
MTT labeling reagent (Roche) for 4 h and then incubated
overnight at 37uC with the solubilization solution (10% SDS in
0.01 M HCl). The viable cells were quantified on a microplate
reader (Bio-Rad) with the absorption spectrum at 595 nm.
Brain fixation and histopathology
The dissected mouse brains were fixed in 4% paraformaldehyde
overnight at 4uC. After fixation, the brains were cryoprotected
with 12–18% sucrose in PBS and embedded in Tissue-Tek OCT
compound (Miles, Elkhart, IN). Coronal sections (10 mm thick)
were prepared from the cerebral cortex and stained with
hematoxylin-eosin (HE) using a standard technique.
For X-gal staining, frozen sections (10 mm thick) were fixed by
0.2% glutaraldehyde in PBS or 4% paraformaldehyde in PBS for
5 min, washed several times, and stained X-gal staining solution
(2 mg/ml X-gal) for 24 hours.
Immunohistochemical analysis was carried out using the
standard ABC method (VECTOR) and fluorescent-dye conjugat-
ed secondary antibodies described above. Primary antibodies used
in this experiment are described above. For Nestin immunostain-
ing, antigen was retrieved by HistoVT One according to the
supplier’s instructions (Nacalai Tesque). After the second antibody
treatment, samples were incubated in peroxidase substrate solution
and then counterstained with hematoxylin. TUNEL assay was
carried out as described previously [33].
Transfection
Transfection was performed using the Nucleofector system,
according to the supplier’s instructions (Amaxa). In brief, 2610
6
cells were suspended in the Mouse NSC Nucleofector Solution
(100 ml) with 10 mg vectors, and were then transfected using the
Nucleofector Device. Transfected cells were cultured in their
optimized medium and selected with puromycin (0.25 mg/ml) and
hygromycin (100 mg/ml). GFP-positive transfected cells were then
purified using a flow cytometer (JSAN) as previously described [33].
Vector construction
Full-length SV40LT cDNA was amplified from pBS-SVT
(Japan Health Sciences Foundation, Tokyo, Japan) using PCR and
Phusion polymerase (FINNZYME, Espoo, Finland), according to
the manufacturer’s instructions. Full-length mouse H-Ras was
amplified from mouse NSC cDNA using RT-PCR and Phusion
polymerase, and H-Ras
L61 was made by substituting a leucine for
the glycine at codon 61 by PCR. Amplified cDNA were cloned
into a pDrive vector (QIAGEN). The nucleotide sequences were
verified using the BigDye Terminator Kit version 3.1 (Applied
Biosystems) and an ABI sequencer model 3130xl (Applied
Biosystems). H-Ras
L61 and SV40LT cDNA were inserted into
pCMS-EGFP vector and pBabe-Puro, resulting in pCMS-EGFP-
H-Ras
L61 and pBabe-Puro-SV40LT, respectively. The following
oligonucleotide DNA primers were synthesized: For the full-length
mouse H-Ras, the 59 primer was 59-TGAATTCGCCACCAT-
GACAGAATACAAGCTTGTGGTG-39 and the 39 primer was
59-ACTCGAGTCAGGACAGCACACATTTGCAG-39. For H-
Ras
L61, the 59 primer was 59-ACAGCAGGTCTAGAAGAGTA-
TA-39 and the 39 primer was 59-TATACTCTTCTAGAC-
CTGCTGT-39. For SV40LT, the 59 primer was 59-AGAATT-
CGCCACCATGGATAAAGTTTTAAACAGAGAG-39 and the
39 primer was 59-AGTCGACTTATGTTTCAGGTTCAGG-
GGG-39.
Statistical analysis
Survival probability was calculated and plotted by Kaplan-
Meier methods. The difference was analyzed using the logrank
test. Comparison of cell growth, differentiation, and X-GAL
induction were performed by the unpaired Student’s t-test.
Comparison of cell viability and cell death after VPA treatment
was performed two-way ANOVA followed by Bonferroni
Gliomagenesis of Prom1- Cells
PLoS ONE | www.plosone.org 8 August 2009 | Volume 4 | Issue 8 | e6869posttests. All statistic analysis was performed using software
GraphPad Prism 5.0 (Graphpad Software).
Supporting Information
Figure S1 Developmental expression pattern of Prom1. X-gal
staining (blue) of frozen sections of E9.5, E12.5, E14.5 and P0
Prom1lacZ,DTA/+ mouse brains. Sections were counterstained
with eosin (red) to visualize cytoplasm. Scale, 200 mm.
Found at: doi:10.1371/journal.pone.0006869.s001 (4.28 MB TIF)
Figure S2 Prom1 antibody labels Prom1-expressing cells in VZ
but not in the other regions. Brain sections of adult Prom1-
lacZ,DTA/+ mice were immunolabeled for b-gal (red) and Prom1
(green). LV, lateral ventricle; DG, dentate gyrus; GL, granular layer.
All nuclei were counterstained with DAPI (blue). Scale, 100 mm.
Found at: doi:10.1371/journal.pone.0006869.s002 (2.02 MB TIF)
Figure S3 Tamoxifen injection decreases body weight of
Prom1lacZ,DTA/+;CreERTM mice but does not affect VZ cells
and their neurogenesis. (A) Relative body weight of mice.
Tamoxifen was injected once a day for five consecutive days and
body weight were measured every five days up to fifteen days after
final injection. PC-TM, tamoxifen-injected Prom1lacZ,DTA/
+;CreERTM mouse; PC-oil, oil-injected Prom1lacZ,DTA/
+;CreERTM mouse; CreER-TM, tamoxifen-injected CreERTM
mouse; Prom1-TM, tamoxifen-injected Prom1lacZ,DTA/+ mouse.
(B) Upper panels show X-gal staining of frozen sections of
tamoxifen-injected Prom1lacZ,DTA/+;CreERTM mouse brains.
Lower four panels indicate PSA-NCAM immunostaining (red) in
the ventricular zone and olfactory bulbs in tamoxifen-injected
Prom1lacZ,DTA/+;CreERTM mice. Arrows show migrating
neuroblasts in rostral migratory stream. All nuclei were counter-
stained with DAPI (blue). LV, lateral ventricle. Scale, 100 mm.
Found at: doi:10.1371/journal.pone.0006869.s003 (2.25 MB TIF)
Figure S4 Brain tumors derived from GICs-LD were labeled for
Nestin but not differentiation markers. Brain sections with tumors
were immunolabeled for GFP (GICs, green) and either neural
stem cell marker (Nestin, red) or differentiation markers, GFAP
(astrocytes, red), MBP (oligodendrocytes, red), NeuN (mature
neurons, red) and NG2 (oligodendrocytes precursor cells, red).
Although most of GFP-positive cells were NG2-negative, very few
double-positive cells were detected. Scale, 100 mm.
Found at: doi:10.1371/journal.pone.0006869.s004 (5.61 MB TIF)
Figure S5 Prom1-expressing cells were adjacent to hypoxic
regions but not to blood vessel. Frozen sections of brain tumors
were stained with X-gal activity and then immunoelabeled for
GFP (green) and either CD31 (marker for endothelrial cells, red)
or HIF1a (marker for hypoxia, red). Arrow heads indicate CD31-
positive cells. Scale, 100 mm.
Found at: doi:10.1371/journal.pone.0006869.s005 (9.60 MB TIF)
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